e-learning
resources
European Respiratory Review
2017
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Systems medicine advances in interstitial lung disease
Flavia R. Greiffo, Oliver Eickelberg, Isis E. Fernandez
Source:
Eur Respir Rev, 26 (145) 170021; 10.1183/16000617.0021-2017
Journal Issue:
September
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Flavia R. Greiffo, Oliver Eickelberg, Isis E. Fernandez. Systems medicine advances in interstitial lung disease. Eur Respir Rev, 26 (145) 170021; 10.1183/16000617.0021-2017
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
The new challenge of CTD-ILD: from basic science to clinical setting
Related content which might interest you:
Systems medicine of COPD
Source: International Congress 2017 – Towards personalised medicine for airways diseases: Deep phenotyping using omics approaches will revolutionise future treatment strategies
Year: 2017
Recent advances in the pathogenesis and clinical evaluation of pulmonary fibrosis
Source: Eur Respir Rev 2012; 21: 48-56
Year: 2012
Translational immunology in genetic lung disease: advances in cystic fibrosis and Alpha-1 anti-trypsin deficiency
Source: International Congress 2014 – From bench to bronchiole: translational immunology and airways disease
Year: 2014
Personalised medicine in interstitial lung diseases
Source: Eur Respir Rev, 27 (148) 170117; 10.1183/16000617.0117-2017
Year: 2018
The genetics of interstitial lung diseases
Source: Eur Respir Rev, 28 (153) 190053; 10.1183/16000617.0053-2019
Year: 2019
Contemporary challenges for specialist nursing in interstitial lung disease
Source: Breathe, 14 (1) 36; 10.1183/20734735.014917
Year: 2018
Advances in interstitial lung diseases
Source: Annual Congress 2011 - Clinical Year in Review I
Year: 2011
Systems medicine in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2010 - Pulmonary rehabilitation and chronic care: new developments in interventions, assessment and care
Year: 2010
Pirfenidone in idiopathic pulmonary fibrosis - Real life experience from a german tertiary referral centre for interstitial lung diseases
Source: Annual Congress 2013 –Diffuse pulmonary fibrosis
Year: 2013
Advanced cell culture techniques and personalised medicine for cystic fibrosis
Source: International Congress 2015 – Respiratory research in the Netherlands
Year: 2015
Molecular pathology and precision medicine for lung cancer
Source: International Congress 2017 – Precision medicine approaches in lung cancer
Year: 2017
Debate – Controversies in interstitial lung disease
Source: ERS webinar 2021
Access for REGISTERED non-members
Year: 2021
Progress in the pathology of diffuse lung disease in infancy: changing concepts and diagnostic challenges
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 978-1-904097-51-8, page=21
Year: 2007
Early diagnosis of fibrotic interstitial lung disease: challenges and opportunities
Source: Virtual Congress 2021 – Interstitial lung diseases: from disease mechanisms to novel treatment options
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept